BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23399652)

  • 41. Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer.
    Spratt DE; Pei X; Yamada J; Kollmeier MA; Cox B; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):686-92. PubMed ID: 22795805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of a Genomic Classifier of Metastatic Risk on Postprostatectomy Treatment Recommendations by Radiation Oncologists and Urologists.
    Nguyen PL; Shin H; Yousefi K; Thompson DJ; Hornberger J; Hyatt AS; Badani KK; Morgan TM; Feng FY
    Urology; 2015 Jul; 86(1):35-40. PubMed ID: 26142578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. National Trends in Prostate Biopsy and Radical Prostatectomy Volumes Following the US Preventive Services Task Force Guidelines Against Prostate-Specific Antigen Screening.
    Halpern JA; Shoag JE; Artis AS; Ballman KV; Sedrakyan A; Hershman DL; Wright JD; Shih YC; Hu JC
    JAMA Surg; 2017 Feb; 152(2):192-198. PubMed ID: 27806151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain.
    Gómez Caamaño A; Zapatero A; López Torrecilla J; Maldonado X
    Clin Transl Oncol; 2016 Sep; 18(9):884-92. PubMed ID: 26621508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Effectiveness of Prostate Cancer Treatment Options: Limitations of Retrospective Analysis of Cancer Registry Data.
    Pearlstein KA; Basak R; Chen RC
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1053-1057. PubMed ID: 30099129
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer.
    Chen RC; Rosenman JG; Hoffman LG; Chiu WK; Wang AZ; Pruthi RS; Wallen EM; Crane JM; Kim WY; Rathmell WK; Godley PA; Whang YE
    BJU Int; 2012 Dec; 110(11 Pt B):E721-6. PubMed ID: 23016517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 1989 patterns of care study for prostate cancer: five-year outcomes.
    Chuba PJ; Moughan J; Forman JD; Owen J; Hanks G
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):325-34. PubMed ID: 11380218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Technology diffusion and diagnostic testing for prostate cancer.
    Schroeck FR; Kaufman SR; Jacobs BL; Skolarus TA; Miller DC; Weizer AZ; Montgomery JS; Wei JT; Shahinian VB; Hollenbeck BK
    J Urol; 2013 Nov; 190(5):1715-20. PubMed ID: 23669564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated prostate cancer centers and over-utilization of IMRT: In regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).
    Rickles DJ
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1280; author reply 1280-1. PubMed ID: 21353167
    [No Abstract]   [Full Text] [Related]  

  • 51. Real-World Practice Patterns and Predictors of Continuous versus Intermittent Androgen Deprivation Therapy Use for Prostate Cancer in Older Men.
    Cheung DC; Alibhai SMH; Martin LJ; Komisarenko M; Dharma C; Warde P; Sridhar SS; Fleshner NE; Kulkarni GS; Finelli A
    J Urol; 2021 Oct; 206(4):933-941. PubMed ID: 34032504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society.
    Pegurri L; Buglione M; Girelli G; Guarnieri A; Meattini I; Ricardi U; Mangoni M; Gabriele P; Bellavita R; Krengli M; Bonetta A; Cagna E; Bunkheila F; Borghesi S; Signor M; Di Marco A; Bertoni F; Stefanacci M; Gatta R; De Bari B; Magrini SM
    Tumori; 2014; 100(1):31-7. PubMed ID: 24675488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
    Lewis SL; Patel P; Song H; Freedland SJ; Bynum S; Oh D; Palta M; Yoo D; Oleson J; Salama JK
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):605-11. PubMed ID: 26867889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
    Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
    BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.
    Panje CM; Dal Pra A; Zilli T; R Zwahlen D; Papachristofilou A; Herrera FG; Matzinger O; Plasswilm L; Putora PM
    Strahlenther Onkol; 2015 Oct; 191(10):778-86. PubMed ID: 25986251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998).
    Magrini SM; Bertoni F; Vavassori V; Villa S; Cagna E; Maranzano E; Pertici M; Pradella R; Spediacci MA; Chiavacci A; Ambrosi E; Livi L; Magli A; Bellavita R; Bossi A; Biti G
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1310-9. PubMed ID: 11955744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer.
    Zelefsky MJ; Chan H; Hunt M; Yamada Y; Shippy AM; Amols H
    J Urol; 2006 Oct; 176(4 Pt 1):1415-9. PubMed ID: 16952647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology.
    Nardi AC; Reis RB; Zequi Sde C; Nardozza A
    Int Braz J Urol; 2012; 38(2):155-64; discussion 164-6. PubMed ID: 22555039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
    Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
    Leite ETT; Ramos CCA; Ribeiro VAB; Salvajoli BP; Nahas WC; Salvajoli JV; Ynoe Moraes F
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1263-1270. PubMed ID: 33346091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.